Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Search for stocks (e.g., AAPL, GOOGL, AMZN)
REGN logo

REGN

NGS
Regeneron Pharmaceuticals Inc.
Healthcare•Biotechnology
Watchlists:
Last updated: Tuesday 15th July 2025
556.87
-13.33 (-2.34%)
Prev Close:570.59
Open:574.15
Bid:556.1
Ask:557.74
52 Week Range
476.49
1,211.20
Volume:1,271,784
Mkt Cap:59,138 M
59
MarketXLS Rank ®
Hold
How are these ranks calculated?
Price Target
$640.40
+15.0%
overviewOptionfinancialsvaluequalitytechnicalestimatespeersnewsTrend Analysis & Forecastdata
Metrics

Valuation

Returns

Growth

EPS
QoQ
N/A
YoY
N/A
Revenue
QoQ
N/A
YoY
N/A
Free Cash Flow
QoQ
N/A
YoY
N/A

Peers

Peers data not available
Available data keys: fn_01356, peerValues

Risk

Dividends

Analyst Estimates

Financial Health

Cash Metrics
Liquidity Ratios
Debt Metrics
Other Metrics
Financial Scores

Technicals

Technical Oscillators
Moving Averages
Volatility Metrics

Profitability

Financials

Financial Statements

REGN - Income Statement (Annual)

Dec-24Dec-23Dec-22Dec-21Dec-20Dec-19Dec-18Dec-17Dec-16Dec-15
Depreciation And Amortization145 M105 M75 M
Gain On Sale Of Security8 M
General And Administrative Expense2,954 M2,631 M2,116 M1,825 M1,346 M1,342 M1,556 M1,320 M1,178 M839 M
Gross Profit Margin (profit Margin After CGS)12,232 M13,117 M10,613 M13,634 M7,377 M6,155 M6,457 M5,670 M4,666 M3,862 M
Interest Expense Non Operating55 M73 M59 M57 M57 M30 M28 M25 M14 M
Interest Income Operating46 M
Misc Other Special Charges844 M225 M179 M436 M291 M250 M47 M24 M6 M-13 M
Net Income (loss)4,413 M3,954 M4,338 M8,075 M3,513 M2,116 M2,444 M1,199 M896 M636 M
Net Income Common Stockholders4,413 M3,954 M4,338 M8,171 M3,513 M2,478 M2,444 M1,199 M1,106 M938 M
Net Income Continuous Operations4,413 M3,954 M4,338 M8,075 M3,513 M2,116 M2,444 M1,199 M896 M636 M
Net Non Operating Interest Income Expense-46 M-45 M-101 M-57 M-57 M-30 M-28 M-25 M-7 M-14 M
Normalized Income3,010 M1,919 M2,017 M1,351 M864 M796 M
Operating Income3,991 M4,047 M4,739 M8,947 M3,577 M2,210 M2,534 M2,080 M1,331 M1,252 M
Operating Income Before Depreciation (EBITDA)5,318 M4,693 M5,260 M9,669 M4,103 M2,670 M2,730 M2,249 M1,435 M1,300 M
Operating Expense8,140 M7,068 M5,619 M4,639 M3,801 M3,583 M3,742 M3,396 M3,230 M2,459 M
Other Gand A2,954 M2,631 M2,116 M1,825 M1,346 M1,342 M1,556 M1,320 M1,178 M839 M
Other Operating Expenses53 M-2 M-90 M-46 M-280 M-209 M-51 M-49 M-46 M-60 M
Rent And Landing Fees5 M4 M17 M15 M
Research Expense5,132 M4,439 M3,593 M2,860 M2,735 M2,450 M2,186 M2,075 M2,052 M1,621 M
Salaries And Wages459 M
Total Income Available For Interest Expense (EBIT)4,835 M4,272 M4,918 M9,383 M3,867 M2,459 M2,582 M2,104 M1,330 M1,225 M
Total Revenues14,202 M13,117 M12,173 M16,072 M8,497 M6,558 M6,711 M5,872 M4,860 M4,104 M
Total Expenses10,110 M7,068 M7,179 M6,413 M4,429 M3,986 M3,996 M3,598 M3,425 M2,701 M
Total Revenue14,202 M13,117 M12,173 M16,072 M8,497 M6,558 M6,711 M5,872 M4,860 M4,104 M
Amord1,163 M1,053 M930 M14 M14 M14 M
Avgshs108 M107 M107 M106 M108 M109 M108 M106 M105 M103 M
Avgshsdt115 M114 M114 M112 M115 M115 M115 M116 M116 M115 M
Basiceps40.937.0540.5176.432.6519.3822.6511.278.556.17
Basicepscont40.937.0540.5176.432.6519.3822.6511.278.556.17
Cor1,971 M1,816 M1,560 M2,438 M1,120 M403 M254 M203 M195 M242 M
Depamor145 M105 M75 M
Dileps38.3434.7738.2271.9730.5218.4621.2910.347.75.52
Dilepscont38.3434.7738.2271.9730.5218.4621.2910.347.75.52
Intinc-25 M-7 M-14 M
Netincdisc4,413 M3,954 M4,338 M8,075 M3,513 M2,116 M2,444 M1,199 M896 M636 M
Othincexp-844 M-225 M-236 M-436 M-291 M-249 M-47 M-24 M-6 M13 M
Pretaxinc4,780 M4,199 M4,859 M9,326 M3,810 M2,429 M2,554 M2,079 M1,330 M1,225 M
Resdev5,132 M4,439 M3,593 M2,860 M2,735 M2,450 M2,186 M2,075 M2,052 M1,621 M
Sga2,954 M2,631 M2,116 M1,825 M1,346 M1,342 M1,556 M1,320 M1,178 M839 M
Shsout109 M110 M109 M109 M107 M220 M219 M215 M212 M210 M
Taxprov367 M246 M520 M1,251 M297 M313 M109 M880 M434 M589 M
<< PREVIOUS STOCK
NEXT STOCK>>
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement "your own" investment strategies in Excel with thousands of MarketXLS functions and templates.
MarketXLS provides all the tools I need for in-depth stock analysis. It's user-friendly and constantly improving. A must-have for serious investors.

John D.

•

Financial Analyst

I have been using MarketXLS for the last 6+ years and they really enhanced the product every year and now in the journey of bringing in AI...

Kirubakaran K.

•

Investment Professional

MarketXLS is a powerful tool for financial modeling. It integrates seamlessly with Excel and provides real-time data.

David L.

•

Financial Analyst

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel.

Lloyd L.

•

Professional Trader